CLINICAL ROLE -
Novel Immunotherapy in Up-front Setting Shows Improved Outcomes in ALL
Study data demonstrate large step forward for this patient population
FLT3 Inhibitors Sustain Prolonged Remission in AML Post HSCT
A retrospective analysis presents unique results for AML treatment.
Highlights From SABCS 2022 Clinical Trial Data
Significant study results may help inform clinical practice strategies.
Highlights From the American Society of Hematology Annual Meeting & Exposition
Developments may soon impact clinical practice in hematology and oncology.
Data in Excess: A Confluence of Oncology/Hematology Conferences Presents Key Clinical Research
In this special January issue covering ASH and SABCS, we have divided the publication by conference.
